Wacker Chemie Ag

Wacker Biotech and Expression Manufacturing Form Strategic Partnership to Accelerate Lentiviral Gene Therapy Development

- Wacker Biotech and Expression Manufacturing have announced a strategic collaboration to advance lentiviral-based gene and cell therapy development and manufacturing. - The partnership combines Wacker's PLASMITEC® plasmid DNA platform with Expression's LentET™ viral vector technology to provide end-to-end manufacturing solutions. - The collaboration aims to streamline supply chains, reduce time to market, and enhance safety standards for viral vector biopharmaceuticals. - Expression's LentET™ platform features ultra-low homology backbones to reduce recombination risks and optimized coding sequences for enhanced potency.